Dilaudid (Hydromorphone HCL) 8mg

Description

Dilaudid (Hydromorphone HCL) 8mg

• NDC 42858-338-01 – Dilaudid® (hydromorphone HCl) Tablets, USP – CII – 8 mg – Rx only – Dispense the accompanying – Medication Guide to each patient. Rhodes – 100 Tablets

. Assess each patient’s risk prior to prescribing DILAUDID Oral Solution or DILAUDID Tablets, and monitor all patients regularly for the development of these behaviors and conditions [https://www.familyfarepharmacy.net/

Dilaudid (Hydromorphone HCL) 8mg

• Limit dosages and durations to the minimum required.
• Follow patients for signs and symptoms of respiratory depression and sedation.https://www.tga.gov.au/resources/artg/67355

• Hydromorphone was positive in the mouse lymphoma assay in the presence of metabolic activation, but was negative in the mouse lymphoma assay in the absence of metabolic activation. Hydromorphone was not mutagenic in the in vitro bacterial reverse mutation assay (Ames assay). Hydromorphone was not clastogenic in either the in vitro human lymphocyte chromosome aberration assay or the in vivo mouse micronucleus assay
• DILAUDID is available as follows: Oral Solution 5 mg/5 mL: a clear, colorless to pale yellow, slightly viscous liquid. NDC 42858-416-16: Bottles of 1 pint (473 mL) 2 mg Tablets: light orange …

NDC 42858-338-01 – Dilaudid® (hydromorphone HCl) Tablets, USP – CII – 8 mg – Rx only – Dispense the accompanying – Medication Guide to each patient. Rhodes – 100 Tablets

DILAUDID is available as follows: Oral Solution 5 mg/5 mL: a clear, colorless to pale yellow, slightly viscous liquid. NDC 42858-416-16: Bottles of 1 pint (473 mL) 2 mg Tablets: light orange …